IP Valuation in the Wake of COVID-19 – Bridging the Divide between Transfer Pricing and Financial Accounting Valuation

The COVID-19 pandemic has had a profound impact on many multinationals and the value of their intangible assets. For financial reporting purposes, many adversely affected multinationals must consider whether the value of their intangible assets has been impaired. Some are considering whether lower intangible asset values might present an opportunity to move these assets within the group at lower tax costs.

In this webcast we will explain how the value of intangible assets for tax purposes can differ materially from the value for financial reporting purposes, when and why a separate valuation for tax purposes is required, and how to bridge the divide between the two. 

To register for this webcast please click here.

Schedule: 4:00 p.m. – 5:00 p.m. BST

Topics

• Arm’s length pricing vs. fair market value
• Hard-to-value intangibles and deviations from forecasts
• Best practices for documenting changes in intangible asset values
• Impact of COVID-19 on IP valuations

Speakers

• Ted Keen, Managing Director, Transfer Pricing, London
• David Ptashne, Director, Transfer Pricing, Chicago
• Daniel Othmann, Vice President, Transfer Pricing, London